91 related articles for article (PubMed ID: 7607504)
21. Detection of pS2 messenger RNA in gynecological cancers.
Wysocki SJ; Hahnel E; Masters A; Smith V; McCartney AJ; Hahnel R
Cancer Res; 1990 Mar; 50(6):1800-2. PubMed ID: 2306733
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa.
Rio MC; Bellocq JP; Daniel JY; Tomasetto C; Lathe R; Chenard MP; Batzenschlager A; Chambon P
Science; 1988 Aug; 241(4866):705-8. PubMed ID: 3041593
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences.
Lu A; Gupta A; Li C; Ahlborn TE; Ma Y; Shi EY; Liu J
Oncogene; 2001 Aug; 20(37):5173-85. PubMed ID: 11526506
[TBL] [Abstract][Full Text] [Related]
25. Modulation of cathepsin-D and pS2 protein levels in human breast cancer cell lines.
Cappelletti V; Fioravanti L; Miodini P; Di Fronzo G
Tumour Biol; 1996; 17(5):290-8. PubMed ID: 8792855
[TBL] [Abstract][Full Text] [Related]
26. Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived.
Ueki T; Walter KM; Skinner H; Jaffee E; Hruban RH; Goggins M
Oncogene; 2002 Mar; 21(13):2114-7. PubMed ID: 11960385
[TBL] [Abstract][Full Text] [Related]
27. Hormonal regulation of synthesis and secretion of pS2 protein relevant to growth of human breast cancer cells (MCF-7).
Kida N; Yoshimura T; Mori K; Hayashi K
Cancer Res; 1989 Jul; 49(13):3494-8. PubMed ID: 2731170
[TBL] [Abstract][Full Text] [Related]
28. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
[TBL] [Abstract][Full Text] [Related]
29. Estrogen-inducible pS2 protein is not the key regulatory component in the proliferation of human breast cancer cells (MCF-7).
Kida N; Yoshimura T; Takahashi H; Nagao S; Nozawa Y; Furukawa Y; Mori K; Hayashi K
Eur J Biochem; 1993 Aug; 215(3):671-6. PubMed ID: 8354273
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of promoter methylation and altered expression of hMLH1 in gastric cancer cell lines with microsatellite instability.
Kang YH; Bae SI; Kim WH
J Cancer Res Clin Oncol; 2002 Mar; 128(3):119-24. PubMed ID: 11935297
[TBL] [Abstract][Full Text] [Related]
31. Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells.
Cavailles V; Garcia M; Rochefort H
Mol Endocrinol; 1989 Mar; 3(3):552-8. PubMed ID: 2664475
[TBL] [Abstract][Full Text] [Related]
32. The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression.
Lefebvre O; Wolf C; Kédinger M; Chenard MP; Tomasetto C; Chambon P; Rio MC
J Cell Biol; 1993 Jul; 122(1):191-8. PubMed ID: 8314841
[TBL] [Abstract][Full Text] [Related]
33. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas.
Tanaka H; Shimada Y; Harada H; Shinoda M; Hatooka S; Imamura M; Ishizaki K
Cancer Res; 1998 Aug; 58(15):3429-34. PubMed ID: 9699676
[TBL] [Abstract][Full Text] [Related]
34. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression.
Deng G; Chen A; Hong J; Chae HS; Kim YS
Cancer Res; 1999 May; 59(9):2029-33. PubMed ID: 10232580
[TBL] [Abstract][Full Text] [Related]
35. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
[TBL] [Abstract][Full Text] [Related]
36. Examination of the DNA methylation properties in nontumorigenic and tumorigenic breast epithelial cell lines.
Pilat MJ; Schwab ED; Yao KL; Pienta KJ
Anticancer Res; 1998; 18(4A):2575-82. PubMed ID: 9703912
[TBL] [Abstract][Full Text] [Related]
37. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
[TBL] [Abstract][Full Text] [Related]
38. Identification of differentially methylated sites within unmethylated DNA domains in normal and cancer cells.
Tryndyak V; Kovalchuk O; Pogribny IP
Anal Biochem; 2006 Sep; 356(2):202-7. PubMed ID: 16824473
[TBL] [Abstract][Full Text] [Related]
39. pS2 is an independent factor of good prognosis in primary breast cancer.
Thompson AM; Hawkins RA; Elton RA; Steel CM; Chetty U; Carter DC
Br J Cancer; 1993 Jul; 68(1):93-6. PubMed ID: 8318427
[TBL] [Abstract][Full Text] [Related]
40. Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis.
Gitan RS; Shi H; Chen CM; Yan PS; Huang TH
Genome Res; 2002 Jan; 12(1):158-64. PubMed ID: 11779841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
